Strategic Clarity. Global Insight. Real-world Impact

Brena Global: where leaders come for decisive insight.

Marketing Intelligence & Strategy

A young woman with dark hair using a laptop, standing in front of a digital world map with glowing connection points.

Deep analysis of HealthTech trends, competitive landscapes, and innovation opportunities across U.S. and EU markets.


Strategic Delivery

Product & Commercialization Strategy

A woman in business attire stands in front of a digital background with health, DNA, and data analysis icons.

Guidance from concept through regulatory readiness and launch balancing speed, compliance, and market fit.

As an advisor who could synthesize 20 years of domain expertise into a single, high-impact consultation, I equipped the client with:

  • A clear diagnostic of which U.S. MedTech verticals are experiencing investment acceleration vs saturation

  • Early indicators that distinguish fundable startups from high-risk ones

  • A roadmap for how CDMOs shape speed, cost, and technical success

  • Regulatory and commercial inflection points across the five device categories

  • Funding landscape patterns influencing Series A–C outcomes

Featured Case Study

Leadership & Ecosystem Development

A woman presenting to a group in a modern office with large windows, whiteboard, and city view.

Global Insight Delivered on Demand: Guiding a Singapore Corporate Innovation Team Through the Complex U.S. MedTech & CDMO Landscape

Advisory for boards, accelerators, and innovation teams on building equitable, high-performing organizations.

Client Need (Problem Statement)

A Singapore-based corporate innovation team needed rapid, expert clarity on the U.S. MedTech startup ecosystem to refine their investment strategy across multiple high-growth device categories. They required:

  • A panoramic view of the U.S. MedTech market

  • Understanding of startup quality signals and failure patterns

  • Insight on CDMO partnerships for early- and mid-stage companies

  • Strategic differentiation across cardio, structural heart, neuromodulation, EP, and vascular

  • A framework to evaluate technical readiness, regulatory pathways, and funding momentum